MedCentral

The Alzheimer’s Association’s International Conference was held July 12-15 in London and online. The following summaries reflect the top highlights of research presented at the meeting. Blood-Based Biomarker May Predict Alzheimer’s Risk 10 Years Before Symptoms Abstract: Buckley RF, Townsend DL, Birkenbihl CJ, et al. The Prognostic Value of p-Tau217 Levels on Progression to Clinical Impairment Over 2, 5, and 10 Years. JAMA. Published online July 14, 2026. doi:10.1001/jama.2026.12556.

Truthful and compassionate. Patient and determined. Productive and present. These are some of the values that come to my mind when I think of the amazing mentors that I have had in my life. These words also set the tone for the type of mentor that I strive to be to my protégés. My career trajectory in dermatology is not marked by a single defining lecture or research project. There is a community of mentors who have helped create the foundation on which I build.

A new Vermont law seeks to prevent leaders of firms that own medical practices from interfering with the decisions and judgments of physicians and other clinicians they employ. Known as HB 583 and signed by Vermont Gov. Phil Scott on June 15, the law is the latest in a series of state actions meant to address concerns about companies, including private equity firms, having increased control over physicians by influencing their actions.

What struck me about the survey results was the percentage [of physicians thinking about] leaving medicine due to “too many clinical demands” and “too many policy shifts.” I see these both as reflective of administrative burden. I suspect that many of the early retirements are also being driven by administrative burden.

Kidney care is evolving rapidly, and the National Kidney Foundation is entering a new chapter of leadership at a pivotal moment in nephrology. Marc Hurlbert, PhD, officially became the organization's chief executive officer on July 1, bringing more than 25 years of experience in biomedical research, nonprofit leadership, public health, and patient advocacy.

More physicians are questioning whether to stay in practice. Nearly half (44%) of respondents to this year’s MedCentral Evolution of Medical Practice survey said they had considered leaving medical practice since the start of 2026, compared with 35% of respondents in last year’s survey. Physicians point to mounting complex clinical demands, persistent stress, and an aging workforce as reasons they are reconsidering their future in medicine.

Physicians reveal the biggest obstacles in their medical practices and share the changes they’ve made to adapt to an evolving healthcare system.

Introduction In MedCentral’s third annual national survey, The Evolution of Medical Practice, physicians shared how they are adapting to challenges at work, while also managing stress and their personal health. More than 800 US-based physicians responded this year, with nearly half saying they’ve considered leaving medical practice since the start of the year. Meet Drops Hear what life with a health condition actually looks like. Now in one app.

The unveiling of the 2026 AHA/ACC/ADA/ASN Cardiovascular-Kidney-Metabolic (CKM) Syndrome guidelines marks a pivotal moment in our approach to patient care. This comprehensive societal statement is a much-needed catalyst for dialogue and action across three intimately intertwined disease processes. As a nephrologist, I view these guidelines with considerable optimism, particularly as the relentless rise of diabetes and obesity continues to challenge our healthcare systems.

The management of hypertension, a key feature of nephritic syndrome, is crucial to the care of patients with immunoglobin A nephropathy (IgAN).